(Q40532880)

21 September 2017

title

Hemodialysis and enzymatic cleavage of methotrexate in man (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90010-5

12 June 2022

1 reference

Frei E 3rd

4

1 reference

21 September 2017

S. B. Howell

0 references

H. E. Blair

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A275059

12 June 2022

J. Uren

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A275059

12 June 2022

E. Frei

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A275059

12 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=275059

12 June 2022

publication date

1 July 1978

1 reference

full work available at URL

21 September 2017

https://api.elsevier.com/content/article/PII:0014296478900105?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90010-5

https://api.elsevier.com/content/article/PII:0014296478900105?httpAccept=text/plain

12 June 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90010-5

European Journal of Cancer

12 June 2022

published in

1 reference

21 September 2017

volume

14

1 reference

21 September 2017

issue

7

1 reference

21 September 2017

page(s)

787-792

1 reference

Recent advances in the chemotherapy of metastatic osteogenic sarcoma

21 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90010-5

Methotrexate and citrovorum factor rescue in the management of childhood lymphosarcoma and reticulum cell sarcoma (non-Hodgkin's lymphomas): parolonged unmaintained remissions

12 June 2022

2

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90010-5

Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer

12 June 2022

4

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90010-5

Renal toxicity of methotrexate

12 June 2022

7

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90010-5

A radioimmunoassay for measurement of serum thymidine

12 June 2022

10

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90010-5

Methotrexate analogs. 3. Synthesis and biological properties of some side-chain altered analogs

12 June 2022

14

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90010-5

The metabolic fate of tritiated methotrexate. II. Absorption and excretion in man

12 June 2022

15

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90010-5

Megaloblastic hematopoiesis in uremia and in patients on long-term hemodialysis

12 June 2022

16

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90010-5

Homeostasis of Folic Acid in Patients Undergoing Maintenance Hemodialysis

12 June 2022

17

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90010-5

A guide to drug therapy in renal failure.

12 June 2022

18

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90010-5

Removal of methotrexate by filtration-adsorption using charcoal filters or by hemodialysis

12 June 2022

21

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90010-5

Enzymatic cleavage of methotrexate provides a method for prevention of drug toxicity

12 June 2022

22

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90010-5

A rapid and specific radioimmunoassay for methotrexate

12 June 2022

9

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90010-5

15 February 2023

Identifiers

1 reference

21 September 2017

1 reference